American policy has crossed the border. According to a trans rights group reported by CBC, some US students at McGill University in Montreal are being denied gender-affirming care at a campus clinic, and the reason given is Trump's executive orders. Let that land for a moment. A Canadian clinic. A Canadian university. Care being withheld not because of Canadian law, not because of any clinical judgement, but because of what one administration in Washington has decided.

What is actually happening here?

The precise mechanism matters, and I want to be honest that the full clinical and legal detail is still emerging. What the CBC report tells us is that trans rights advocates are raising the alarm about US students being turned away from gender-affirming care at McGill's student health services, with Trump's executive orders cited as the reason. Whether that is the clinic acting out of legal caution, responding to funding conditions, or something else is not yet fully clear. But the effect is the same: trans people who moved to Canada, in some cases precisely because the United States had become unsafe for them, are finding that American political decisions have followed them there.

This is not a bureaucratic footnote

Some of the students affected will have left the US because access to gender-affirming care was already being stripped away at home. Canada represented safety. McGill represented a fresh start. And now, at the moment they needed care, they were told no, and the reason cited was the policy of a government they had already put a national border between themselves and.

That is not a bureaucratic footnote. That is the long arm of authoritarian policy reaching into another country's healthcare decisions and touching the most personal aspects of someone's life. If accurate, it represents something genuinely new: the export of healthcare denial across sovereign borders.

What does good care look like here?

Gender-affirming care for trans people is supported by the WPATH Standards of Care 8 and the Endocrine Society guidelines. It is not experimental, not controversial in any serious clinical sense, and not something that should be subject to executive veto, whether in Washington or anywhere else. A student presenting to a clinic with a healthcare need is a patient. Their care should be governed by clinical evidence and by the law of the country they are in, full stop.

Canada has legal protections for trans people. Canadian healthcare institutions operate under Canadian law. If a clinic is using a US executive order to justify denying care to a person on Canadian soil, that decision deserves serious scrutiny, both legally and ethically.

Why this matters beyond McGill

This story is a signal, not an isolated incident. We are watching the effects of a deliberate political campaign to make trans healthcare impossible: not just in the US, but wherever American institutional power, funding conditions, or legal fear can reach. Universities with US funding ties, international organisations with US partners, clinics that serve US nationals abroad, all of these are now potential pressure points.

Trans people deserve to know that when they cross a border seeking safety, the safety is real. Right now, that is not guaranteed. And the people being hurt are not abstractions in a policy debate; they are students who went to university in Montreal and needed a prescription or a consultation and were turned away.

I will be watching how McGill responds to this. And I think every institution that provides gender-affirming care, wherever it sits in the world, needs to ask itself the same question: whose law are we actually practising under?

If this is useful to you, please share it. Every share helps more people find accurate information about gender diversity.